<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Variants in the fat-mass and <z:hpo ids='HP_0001513'>obesity</z:hpo>-associated gene (FTO) influence susceptibility to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> via an effect on <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e>/<z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Given the important role of <z:hpo ids='HP_0001513'>obesity</z:hpo> in the aetiology of both <z:hpo ids='HP_0000147'>polycystic ovary</z:hpo> syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e>) and type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, our aim was to establish whether FTO variants are also implicated in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e> susceptibility </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We performed a genetic association study of FTO variant rs9939609 using case-control analyses, conducted in 463 PCOS patients (geometric mean BMI 27.5 kg/m(2)) and 1,336 female controls (geometric mean BMI 25.3 kg/m(2)) of UK British/Irish origin </plain></SENT>
<SENT sid="3" pm="."><plain>We also sought evidence for associations between FTO variation and circulating <z:chebi fb="51" ids="17347">testosterone</z:chebi> levels in 324 UK <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e> patients and 1,000 women from the Northern Finland Birth Cohort of 1966 </plain></SENT>
<SENT sid="4" pm="."><plain>Outcome measures included FTO rs9939609 genotype frequencies by participant group and <z:chebi fb="3" ids="50113">androgen</z:chebi> measures (<z:chebi fb="51" ids="17347">testosterone</z:chebi>, free <z:chebi fb="3" ids="50113">androgen</z:chebi> index) by genotype </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: There was a significant association between FTO genotype and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e> status in the UK case-control analysis, which was attenuated by adjustment for BMI (Cochran-Armitage test, odds ratio [per minor allele copy] 1.30 [95% CI 1.12, 1.51], p = 7.2 x 10(-4) [unadjusted], p = 2.9 x 10(-3) [adjusted]) </plain></SENT>
<SENT sid="6" pm="."><plain>This association was most evident in <z:mp ids='MP_0001261'>obese</z:mp> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e> patients (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e> patients below median BMI vs UK controls, p = 0.11; above median BMI vs controls, p = 2.9 x 10(-4)) </plain></SENT>
<SENT sid="7" pm="."><plain>No relationship between FTO genotype and <z:chebi fb="3" ids="50113">androgen</z:chebi> levels was seen </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS/INTERPRETATION: We provide the first evidence that variants that predispose to common <z:hpo ids='HP_0001513'>obesity</z:hpo> also result in altered susceptibility to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e>, confirming the mechanistic link between these conditions </plain></SENT>
<SENT sid="9" pm="."><plain>The predominant effect of FTO variants on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e> susceptibility is probably mediated through <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> </plain></SENT>
</text></document>